Publications

Showing

0

out of

0

results

Prevalence of cerebral amyloid pathology in persons without Cognitive impairment and dementia: a meta-analysis.

Jansen WJ, Ossenkoppele R, Knol DL,

May 18, 2015

Impact of the environment on multiple sclerosis.

Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T.

May 18, 2015

Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.

Helland CB, Holmøy T, Gulbrandsen P.

April 30, 2015

Genome-wide analysis of attention deficit hyperactivity disorder in Norway.

Zayats T, Athanasiu L, Sonderby I,

April 12, 2015

First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study.

Andreasen N, Simeoni M, Ostlund H,

March 18, 2015

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI,

March 14, 2015

The assessment of carotid atherosclerosis using a new multipurpose ultrasound probe.

Evensen K, Dahl A, Ronning OM, Russell D.

February 28, 2015

Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.

Desikan RS, Schork AJ, Wang Y,

January 11, 2015

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.

Cortese M, Riise T, Bjørnevik K,

January 11, 2015

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Røsjø E, Steffensen LH, Jørgensen L,

January 11, 2015